Pulmonary Fibrosis Foundation Community Registry

This is an observational study, meaning it doesn't test a new medicine or treatment, but rather collects information about people living with pulmonary fibrosis (PF) and related lung conditions. You can join if you are 18 or older and have PF, or if you are a caregiver or family member of someone with PF. The goal is to gather information from 10,000 patients, caregivers, and family members over three years to help researchers better understand PF. This study is currently open for enrollment.

Study design
This is an observational, longitudinal cohort study that aims to enroll 10,000 participants.
What's involved
You would self-enroll online and contribute data by answering a series of surveys at regular intervals.
Compensation
Not stated in the trial record.
Follow-up
The study aims to measure the number of enrolled participants at 3 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05382572

Pulmonary Fibrosis Foundation Community Registry

Recruiting
Not specifiedAges 18+Observational
Pulmonary Fibrosis Foundation
~10,000 participants
Updated 2025-04-11 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of patients who have or had interstitial lung disease (ILD) enrolled in the PFF Community Registry
Measured over 3 years
+2 more outcomes measured
Pulmonary Fibrosis
Interstitial Lung Disease
Lung Fibrosis
Idiopathic Pulmonary Fibrosis
1 sites across 1 states
Illinois1
  • Kevin R Flaherty, MD · STUDY_CHAIR · Pulmonary Fibrosis Foundation

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Sarcoid
Lymphangioleiomyomatosis (LAM)
Pulmonary alveolar proteinosis (PAP)
Cystic fibrosis (CF)
Amyloidosis
  • Number of patients who have or had interstitial lung disease (ILD) enrolled in the PFF Community Registry3 years
  • Number of caregivers of patients who have or had ILD enrolled in the PFF Community Registry3 years
  • Number of family members of patients who have or had ILD enrolled in the PFF Community Registry3 years